Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Qualifizierte Beratung für Inkontinenzhilfsmittel: Das Verbesserungspotenzial ist erheblich.
Manseck A, Piotrowski A, Butea-Bocu M, Foller S, Gleissner J, Kahlmeyer A, Karstedt H, Kirschner-Hermanns R, Liebald T, Linné C, Moll V, Otto U, Schorn A, Stein J, Wagner A, Wiedemann A. Manseck A, et al. Among authors: foller s. Procare. 2022;27(6-7):12-17. doi: 10.1007/s00735-022-1581-0. Epub 2022 Sep 9. Procare. 2022. PMID: 36161070 Free PMC article. German.
Tailored immunotherapy approach with nivolumab with or without ipilimumab in patients with advanced transitional cell carcinoma after platinum-based chemotherapy (TITAN-TCC): a multicentre, single-arm, phase 2 trial.
Grimm MO, Grün CB, Niegisch G, Pichler M, Roghmann F, Schmitz-Dräger B, Baretton G, Schmitz M, Bolenz C, Foller S, Leucht K, Schumacher U, Schostak M, Meran J, Loidl W, Zengerling F. Grimm MO, et al. Among authors: foller s. Lancet Oncol. 2023 Apr;24(4):347-359. doi: 10.1016/S1470-2045(23)00053-0. Epub 2023 Feb 28. Lancet Oncol. 2023. PMID: 36868252 Clinical Trial.
S2k-Leitlinie Hilfsmittelberatung.
Butea-Bocu M, Foller S, Gleisner J, Kahlmeyer A, Karstedt H, Kirschner-Hermanns R, Liebald T, Linne C, Manseck A, Moll V, Otto U, Piotrowski A, Schorn A, Stein J, Wagner A, Wiedemann A; Als Mandatsträger weiterer Fachgesellschaften: Dt. Gesellschaft für Geriatrie: Dr. Klaus Becher; Dt. Gesellschaft für Gynäkologie und Geburtshilfe: Prof. Dr. Christl Reisenauer; Dt. Kontinenz Gesellschaft e. V.: Prof. Dr. Daniela Schultz-Lampel; GKV-Spitzenverband: Dr. Christine Kuhlmann; Dt. Gesellschaft für Pflegewissenschaften: Dr. Daniela Hayder-Beichel; Inkontinenz Selbsthilfe e. V.: Mathias Zeisberger. Butea-Bocu M, et al. Among authors: foller s. Aktuelle Urol. 2021 Apr;52(2):168-180. doi: 10.1055/a-1293-2831. Epub 2021 Apr 1. Aktuelle Urol. 2021. PMID: 33822346 German. No abstract available.
[Guidelines for consultations regarding incontinence care products].
Manseck A, Piotrowski A, Butea MC, Foller S, Gleissner J, Kahlmeyer A, Karstedt H, Kirschner-Hermanns R, Liebald T, Linné C, Moll V, Otto U, Schorn A, Stein J, Wagner A, Wiedemann A. Manseck A, et al. Among authors: foller s. Urologe A. 2022 Jan;61(1):3-12. doi: 10.1007/s00120-021-01721-3. Epub 2022 Jan 10. Urologe A. 2022. PMID: 35006283 Review. German.
[Adverse events of immune checkpoint inhibitors].
Foller S, Oppel-Heuchel H, Fetter I, Winkler Y, Grimm MO. Foller S, et al. Urologe A. 2017 Apr;56(4):486-491. doi: 10.1007/s00120-017-0342-3. Urologe A. 2017. PMID: 28246759 German.
[Follow-up of renal cell carcinoma in a nonmetastatic stage].
Szabados B, Foller S, Schulz GB, Staehler M, Grimm MO, Stief CG, Casuscelli J. Szabados B, et al. Among authors: foller s. Urologe A. 2019 Jan;58(1):65-76. doi: 10.1007/s00120-018-0823-z. Urologe A. 2019. PMID: 30627750 German.
41 results